Trends in Prescription Opioid and Nonopioid Analgesic Use by Race, 1996–2017

The Skeletal Oncology Research Group Machine Learning Algorithm (SORG-MLA) for predicting prolonged postoperative opioid prescription after total knee arthroplasty: an international validation study using 3,495 patients from a Taiwanese cohort

“…Second, the time-period of this study (2010–2018) was different from that of the developmental cohort (2000–2018). Because both the physicians and the patients have recently become more alert to the PPOU [ 22 ], the historical background between the two cohorts might be different. Third, there are major differences in pharmaceutical regulation and prescription philosophy between the two countries [ 23 ].…”

“…Third, there are major differences in pharmaceutical regulation and prescription philosophy between the two countries [ 23 ]. Despite the historical and legislative differences, the algorithm has held its good discriminatory ability and overall performance as being successfully tested by decision curve analysis in our geographically distinct cohort [ 22 , 22 ]. The difference in PPOU between both cohorts could be influenced by various factors including pharmaceutical philosophy, legal regulations, and socioeconomic factors.…”

Racial inequities in opioid use disorder management: can the anesthesiologist improve outcomes?

“…At the beginning of the opioid epidemic, White individuals were disproportionately affected by prescription opioid misuse 19. The prevalence of prescription opioid use, which parallels opioid misuse, was 11.9% in the White population, compared with 9.3% in Black and 9.6% in Hispanic populations in the mid-1990s 20. This is likely related to racial disparities in pain treatment that translated to less frequent opioid use in minority patients during the years when opioids were initially liberalized 21–24.…”

“…19 The prevalence of prescription opioid use, which parallels opioid misuse, was 11.9% in the White population, compared with 9.3% in Black and 9.6% in Hispanic populations in the mid-1990s. 20 This is likely related to racial disparities in pain treatment that translated to less frequent opioid use in minority patients during the years when opioids were initially liberalized. [21][22][23][24] Some of the documented disparities in pain treatment include limited access to analgesics in minority neighborhoods, differential worker's compensation for pain-related claims, and biases in pain assessment and analgesic prescription.…”

CORR Insights®: Are There Differences in Postoperative Opioid Prescribing Across Racial and Ethnic Groups? Assessment of an Academic Health System

“…Many prior studies reporting disparities in opioid prescribing patterns have relied on retrospective data collected from large national databases [2,4,7,11,13,15,16]. In contrast to the current study [12], these analyses often used aggregated data from various hospitals across the United States, which may have represented disparities arising not only at the intra-health systems level (that is, in an individual healthcare system or hospital), but also at the inter-health systems level (between separate healthcare systems and hospitals) [11].…”